Regulatory Science Innovations Catalyzing Medical Device Development September 25, 2026

https://www.fda.gov/medical-devices/medical-devices-news-and-events/regulatory-science-innovations-catalyzing-medical-device-development-09252026?utm_medium=email&utm_source=govdelivery Public Meeting: Regulatory Science Innovations Catalyzing Medical Device Development – September 25, 2026 The Food and Drug Administration (FDA) is announcing a public meeting entitled “Regulatory Science Innovations Catalyzing Medical Device Development.” The meeting is co-sponsored with the Medical Device Innovation Consortium (MDIC). The purpose of the meeting is to engage stakeholders in advancing regulatory science in support of breakthrough and disruptive medical device technologies by fostering meaningful, multi-stakeholder dialogue that informs long-term research priorities and strategic planning for FDA’s Center for Devices and Radiological Health (CDRH). Through this collaboration, CDRH and MDIC seek to proactively identify the regulatory science challenges that will shape the future of medical device development over the next decade. Date: September 25, 2026 Time: 8:30 a.m. to 4:30 p.m. ET Location: The meeting will be in-person on the FDA’s White Oak Campus and webcast (listening only). Registration Deadline: In-person registration (available on a first-come, first-served basis) is open through September 10, 2026. Virtual registration is open until September 20, 2026. https://mdic.org/?utm_medium=email&utm_source=govdelivery